Navigation Links
Vion Pharmaceuticals Announces Initiation of a Phase I/II Trial of Cloretazine(R) (VNP40101M) in Combination with Temodar(R) in Adult Brain Tumors
Date:9/17/2007

NEW HAVEN, Conn., Sept. 17 /PRNewswire-FirstCall/ -- VION PHARMACEUTICALS, INC. (Nasdaq: VION) today announced that an investigator-sponsored trial of its lead anti-cancer agent Cloretazine(R) (VNP40101M) in combination with Temodar(R) (temozolomide) in relapsed or progressive adult malignant gliomas had been initiated at the Robert H. Lurie Cancer Center under the direction of Dr. Jeffrey J. Raizer, Principal Investigator.

The objective of the trial is to establish the maximum tolerated dose (MTD) and safety profile of Cloretazine(R) (VNP40101M) in combination with temozolomide and then to study this dose in an expanded number of patients. Cohorts of 3-6 patients receive escalating doses of Cloretazine(R) (VNP40101M) until the MTD is determined (Phase I). In Phase II, response rates, progression-free survival and overall survival will be evaluated in addition to the safety profile. Patients receive oral temozolomide on days 1-7 and intravenous Cloretazine(R) (VNP40101M) over 15-30 minutes 2 hours after the last dose of temozolomide on day 7. Treatment repeats every 7 weeks in the absence of disease progression or unacceptable toxicity.

Correlative studies conducted as part of the trial will measure: (i) the level of O6 alkylguanine DNA alkyltransferase (AGT) expression in peripheral blood monocytes before treatment with temozolomide and just prior to the administration of Cloretazine(R) (VNP40101M); (ii) the status of O6- methylguanine-methyltransferase (MGMT) methylation as well as other methylation patterns in plasma from patients treated with this regimen relative to outcome; and (iii) Cloretazine(R) (VNP40101M) in the cerebral spinal fluid and serum/plasma in Phase II.

Dr. Raizer commented, "One
'/>"/>

SOURCE Vion Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
2. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
5. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
6. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
7. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
8. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
9. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
10. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
11. Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple Myeloma and Waldenstroms Macroglobulinemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... -- CTI BioPharma Corp. (NASDAQ and MTA: CTIC) today reported ... 2015. "After reporting positive top-line ... pacritinib during the quarter, we have subsequently received positive ... excited by the potential opportunity for pacritinib to meet ... patients with myelofibrosis, specifically in the portion of patients ...
(Date:5/6/2015)... Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ) today reported ... The net loss and the loss from operations for ... respectively, compared to $10.7 million and $8.8 million during ... 2015, Alexza had consolidated cash, cash equivalents, marketable securities, ... continue to focus on ways in which to drive ...
(Date:5/6/2015)... 2015 The Parenteral Drug Association (PDA) Board ... with Richard M. Johnson to continue as ... very pleased to have Richard Johnson continue ... , the Chair of the Board of Directors. "Under ... Richard has led a strong staff and dedicated volunteers, ...
Breaking Medicine Technology:CTI BioPharma Reports First Quarter 2015 Financial Results 2CTI BioPharma Reports First Quarter 2015 Financial Results 3CTI BioPharma Reports First Quarter 2015 Financial Results 4CTI BioPharma Reports First Quarter 2015 Financial Results 5CTI BioPharma Reports First Quarter 2015 Financial Results 6CTI BioPharma Reports First Quarter 2015 Financial Results 7CTI BioPharma Reports First Quarter 2015 Financial Results 8CTI BioPharma Reports First Quarter 2015 Financial Results 9Alexza Reports 2015 First Quarter Financial Results 2Alexza Reports 2015 First Quarter Financial Results 3Alexza Reports 2015 First Quarter Financial Results 4Alexza Reports 2015 First Quarter Financial Results 5Alexza Reports 2015 First Quarter Financial Results 6Alexza Reports 2015 First Quarter Financial Results 7Alexza Reports 2015 First Quarter Financial Results 8Alexza Reports 2015 First Quarter Financial Results 9Alexza Reports 2015 First Quarter Financial Results 10PDA Extends Richard M. Johnson as President/CEO for Six Additional Years 2
... , Study Discussed at the American Podiatric Medical ... Md., July 30 Foot complications, such as open wounds and ulcers, ... treat. However, a new wound dressing powder, which acts very much ... and reduce the amount of pain that a patient suffering from a ...
... , PHILADELPHIA, July 29 Pediatric researchers ... the development of type 2 diabetes also predisposes children to having ... genetic influence on how prenatal events may set the stage for ... Researchers from The Children,s Hospital of Philadelphia and the University ...
Cached Medicine Technology:New Powder Speeds Healing of Difficult Foot Wounds 2Diabetes Gene Raises Odds of Lower Birth Weight 2Diabetes Gene Raises Odds of Lower Birth Weight 3
(Date:5/7/2015)... (PRWEB) May 07, 2015 Over a lifetime, ... A broken tooth or a failing crown usually means a ... dentist result in more needle pokes to the gums, ... the new crown is fabricated. In addition, it takes time ... time than necessary. In the dental chair, Dr. Leonard Umanoff, ...
(Date:5/6/2015)... With recent headlines about the kidnapping of Bossini ... men from Southern China, it is becoming apparent to people ... for them. This is especially true for High Net Worth ... attention through the property they own, the schools their children ... those individuals, families and companies that are at higher risk ...
(Date:5/6/2015)... As the exclusive hospital of the Tampa Bay Buccaneers, ... at Raymond James Stadium for all the “Bucs Babies” celebrating ... drafted into the “Bucs Babies” program last year. , ... children, particularly those born at the Florida Hospitals here in ... I really enjoyed my time participating in the festivities, interacting ...
(Date:5/6/2015)... Sulphur Springs, Texas (PRWEB) May 06, 2015 ... the stages of the HIMSS EMR Adoption Model, ... remove paper, improve patient engagement and automate processes. ... had transitioned from paper-driven to electronic workflows, patient ... to hard copies of consents. With HIMSS Stage ...
(Date:5/6/2015)... 2015 Experienced Vancouver air conditioning installation ... that they will now conduct their cooling services, including ... addition to commercial and residential units. Strata complex air ... lot of technical knowledge as well as a professionally ... we will take away any old air conditioning unit ...
Breaking Medicine News(10 mins):Health News:Dr. Leonard Umanoff, DDS Uses New CEREC Crowns that Save Time for Dental Patients 2Health News:Pacific Prime China Now Offering Kidnapping & Ransom Insurance 2Health News:Florida Hospital and the Tampa Bay Buccaneers Celebrate “Bucs Babies” Who are Turning One this Month with a Party on the Pirate Ship 2Health News:Florida Hospital and the Tampa Bay Buccaneers Celebrate “Bucs Babies” Who are Turning One this Month with a Party on the Pirate Ship 3Health News:Access Electronic Patient Signatures Help Hilo Meet HIMSS Stage 7 Paperless Targets & Save $200,000 a Year on Consent Forms 2Health News:Access Electronic Patient Signatures Help Hilo Meet HIMSS Stage 7 Paperless Targets & Save $200,000 a Year on Consent Forms 3Health News:Pro Ace Care Now Does Air Conditioning Installation for Strata Complexes 2
... ... Nevada will highlight the fundamentals of the Federal and California False Claims Acts at a ... Association (NCMA). The meeting will be from 11:30 - 1:30 at the La Boheme ... ...
... , WASHINGTON , Feb. 15 ... Census Bureau: , (Logo: http://www.newscom.com/cgi-bin/prnh/20090226/CENSUSLOGO ) , ... Profile America — Monday, February 15th .  On ... the first American to win the women,s World Figure Skating Championship, ...
... of the Journal of Clinical Sleep Medicine shows ... increase the risk of motor vehicle accidents in adolescents. ... have had a crash if they experienced sleepiness while driving ... (OR = 1.9). Eighty of the 339 students had ...
... Training ... Africa , ... Luanda, Angola (PRWEB) February 15, 2010 -- Top global companies and the President’s ... training program to arm the country’s malaria fighters with state-of-the-art mosquito surveillance and vector ...
... 14 Local businesses and the Change Your ... the Susan G. Komen for the Cure, Phoenix Affiliates on ... "Change Your Game! Day" will be comprised of a ... Golf Course, 1125 East Rio Salado Parkway, and Tempe Marketplace, 2000 ...
... therapeutic targets for patients with the cystic fibrosis, a ... School of Medicine has identified a defective signaling pathway ... in the journal Nature Medicine , the researchers ... peroxisome proliferator-activated receptor-γ (PPAR-γ) accounts for a portion of ...
Cached Medicine News:Health News:Nevada Qui Tam Attorney Tim Terry to Address Sacramento Gold Rush Chapter of the National Contract Management Association (NCMA) 2Health News:U.S. Census Bureau Daily Feature for Feb. 15 2Health News:Sleep problems and sleepiness increase the risk of motor vehicle accidents in adolescents 2Health News:Private Sector, President's Malaria Initiative Join Forces to Strengthen Angolas Capacity to Control Mosquitoes 2Health News:Private Sector, President's Malaria Initiative Join Forces to Strengthen Angolas Capacity to Control Mosquitoes 3Health News:Private Sector, President's Malaria Initiative Join Forces to Strengthen Angolas Capacity to Control Mosquitoes 4Health News:Private Sector, President's Malaria Initiative Join Forces to Strengthen Angolas Capacity to Control Mosquitoes 5Health News:Private Sector, President's Malaria Initiative Join Forces to Strengthen Angolas Capacity to Control Mosquitoes 6Health News:Businesses Rally Big Efforts to Benefit the Susan G. Komen Phoenix Affiliates' Fight Against Breast Cancer 2Health News:Businesses Rally Big Efforts to Benefit the Susan G. Komen Phoenix Affiliates' Fight Against Breast Cancer 3Health News:Defective signaling pathway sheds light on cystic fibrosis 2
... BD Cell-Tak™ Cell and Tissue Adhesive ... from Mytilus edulis (marine mussel). These proteins ... secreted by the mussel to anchor itself ... BD Cell-Tak Cell and Tissue Adhesive is ...
... GE Healthcare is known ... best-in-class analysis programs for ... monitoring device. With advanced ... Gender-Specific, and ACI-TIPI, GE ...
... The Affinity pacemaker family ... smallest, truly automatic devices. ... combination of advanced technologies ... DR pacemaker incorporates the ...
... a small bench top chemistry analyzer that utilizes ... strips with results available within 8 - 15 ... The instrument accepts whole blood samples and is ... card. At the conclusion of testing, results are ...
Medicine Products: